Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Brain tumour breakthrough

Friday 28 March 1997 19:02 EST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Scientists believe they have identified a gene that triggers brain tumours, in what has been described as a potentially "major discovery". The defective gene was found in about a third of tumour samples of the most lethal form of brain cancer, glioblastoma multiforme. Similar gene mutations were seen in some prostate and breast cancer cells.

The gene, known as PTEN, is believed to be involved in controlling cell growth, preventing the kind of rampant cell division that leads to cancer. It is thought mutations in the cancerous gene may deactivate it, allowing tumours to develop.

The findings, from a team of researchers led by Jing Li, of Columbia University College of Physicians and Surgeons in New York, were published yesterday in the American journal Science.

Glioblastoma multiforme kills between 5,000 and 6,000 people a year in the US. There are no similar figures available in the UK, but all types of brain and central nervous system tumours together account for about 2 per cent of deaths in western countries. Their overall incidence is between one and 15 deaths per 100,000 of population.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in